Laura Brege, Director: Acadia Pharmaceuticals ACAD Sell · Filed 23/01/17

Trade details

Type: Insider sale
Amount: $228,125
Shares · price: 12,500 sh · $18.25 a share
Held after: 0 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Laura BregeDirector
Trade date: 23/01/12
Filed: 23/01/17
Days to filing: 5 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/13~23/02/11

Laura Brege's recent trades

Laura BregeDirector
SellMirum Pharmaceuticals
Sell
Mirum Pharmaceuticals
MIRM
$1.2M
15,509 sh
$1.2M
Filed 25/09/12
Traded 25/09/11
Laura BregeDirector
SellMirum Pharmaceuticals
Sell
Mirum Pharmaceuticals
MIRM
$111.9K
1,491 sh
$111.9K
Filed 25/09/12
Traded 25/09/11
Laura BregeDirector
Planned saleMirum Pharmaceuticals
Planned sale
Mirum Pharmaceuticals
MIRM
$1.3M
17,000 sh
$1.3M
Filed 25/09/11
Traded 25/09/11
Laura BregeDirector
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$314.6K
14,446 sh
$314.6K
Filed 25/06/05
Traded 25/06/04
Laura BregeDirector
Planned saleAcadia Pharmaceuticals
Planned sale
Acadia Pharmaceuticals
ACAD
$314.6K
14,446 sh
$314.6K
Filed 25/06/04
Traded 25/06/04